Evidence map›Paper›PMID 31300897›Full record

ArticleJournal of medical systems2019

The Application of Deep Learning in the Risk Grading of Skin Tumors for Patients Using Clinical Images.

Xin-Yu Zhao, Xian Wu, Fang-Fang Li, Yi Li, Wei-Hong Huang, Kai Huang, Xiao-Yu He, Wei Fan, Zhe Wu, Ming-Liang Chen and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of medical systems, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Automated cutaneous squamous cell carcinoma grading using deep learning with transfer learning.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xin-Yu ZhaoSchool of Automation, Central South University, Changsha, China.
Xian WuTencent Medical AI Lab, Beijing, China.
Fang-Fang LiDepartment of Dermatology, Xiangya Hospital Central South University, Changsha, China.
Yi LiSchool of Automation, Central South University, Changsha, China.
Wei-Hong HuangMobile Health Ministry of Education - China Mobile Joint Laboratory, Xiangya Hospital Central South University, Changsha, China.
Kai HuangDepartment of Dermatology, Xiangya Hospital Central South University, Changsha, China.
Xiao-Yu HeSchool of Automation, Central South University, Changsha, China.
Wei FanTencent Medical AI Lab, Beijing, China.
Zhe WuSchool of Automation, Central South University, Changsha, China.
Ming-Liang ChenDepartment of Dermatology, Xiangya Hospital Central South University, Changsha, China.
Jie LiDepartment of Dermatology, Xiangya Hospital Central South University, Changsha, China.
Zhong-Ling LuoDepartment of Dermatology, Xiangya Hospital Central South University, Changsha, China.
Juan SuDepartment of Dermatology, Xiangya Hospital Central South University, Changsha, China.
Bin XieSchool of Automation, Central South University, Changsha, China. xiebin@csu.edu.cn.ORCID http://orcid.org/0000-0003-2135-0694
Shuang ZhaoDepartment of Dermatology, Xiangya Hospital Central South University, Changsha, China. shuangxy@csu.edu.cn.

Funding

Hunan Provincial Science and Technology Department 2018SK2092National Key R&D Program of China 2018YFC0117000Specialized Basic Work of Science and Technology 2015FY111100
6 · The paper itself

Abstract

According to diagnostic criteria, skin tumors can be divided into three categories: benign, low degree and high degree malignancy. For high degree malignant skin tumors, if not detected in time, they can do serious harm to patients' health. However, in clinical practice, identifying malignant degree requires biopsy and pathological examination which is time costly. Furthermore, in many areas, due to the severe shortage of dermatologists, it's inconvenient for patients to go to hospital for examination. Therefore, an easy to access screening method of malignant skin tumors is needed urgently. Firstly, we spend 5 years to build a dataset which includes 4,500 images of 10 kinds of skin tumors. All instances are verified pathologically thus trustworthy; Secondly, we label each instance to be either low-risk, high-risk or dangerous in which Junctional nevus, Intradermal nevus, Dermatofibroma, Lipoma and Seborrheic keratosis are low-risk, Basal cell carcinoma, Bowen's disease and Actinic keratosis are high-risk, Squamous cell carcinoma and Malignant melanoma are dangerous; Thirdly, we apply the Xception architecture to build the risk degree classifier. The area under the curve (AUC) for three risk degrees reach 0.959, 0.919 and 0.947 respectively. To further evaluate the validity of the proposed risk degree classifier, we conduct a competition with 20 professional dermatologists. The results showed the proposed classifier outperforms dermatologists. Our system is helpful to patients in preliminary screening. It can identify the patients who are at risk and alert them to go to hospital for further examination.

Indexed as

Deep LearningPatient ParticipationArea Under CurveCell PhoneCutaneous Malignant MelanomaDatabases, FactualHumansMelanomaNeural Networks, ComputerSkin NeoplasmsConvolutional neural networkPreliminary screeningRisk gradeSkin tumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.